glp 1 for pediatrics Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Pediatric Obesity | Current Treatment Options in Pediatric reference values for glucagon-like
Description
Acknowledgements: The authors thank Steven Lamberti, MD, for his critical advice and review of the manuscript
FAQ 5: Should I stop taking my GLP-1 medication if Im experiencing hair loss
However, real-world adherence to these medications beyond the short term remains a concern, with previous studies indicating adherence rates between 20% and 50% after 12 months 1-4
Truveta and collaborators partnered on a new large-scale study that considers the potential benefits of GLP-1 RA for AUD, among those with diabetes and/or obesity
